29 October 2009

Johnson & Johnson and UCL have recently jointly established a co-managed £270,000 proof of concept fund. The fund will be managed through UCLB and the aim of the fund is to improve the research pipeline in early stage healthcare research and to generate benefit for patients, the healthcare system and the life science industry.

The maximum award for any one application is £30,000.

The first call for applications is concentrated in the areas of obesity & diabetes, heart failure & CVD and neurodegenerative diseases. Applications should be submitted in the form of a short non-confidential abstract with a description and keywords for the project of no longer than 2 A4 pages.A brief researcher biography, stage of development and intellectual property status of proposed project and proposed healthcare application/relevance should also be included.

The abstracts will be selected by UCLB for submission to J&J. If the abstract is successful, the researcher/researchers will be required to submit a full application in the form of a proof of concept application using the UCLB standard PoC form for review by a joint J&J UCL PoC committee.

The closing date for submission of abstracts is 5pm 15th January 2010, and applications should be submitted to Mr. Alex Weedon, Legal Manager, UCLB (a.weedon@uclb.com).

UCLB Business Managers will be able to provide help and advice for submission of abstracts. Please visit the UCLB contacts page to find your UCLB Business Manager.